EUVIMEDEUVIMED entdecken
Crossref

LT-102, an AMPA receptor potentiator, alleviates depression-like behavior and synaptic plasticity impairments in prefrontal cortex induced by sleep deprivation

Yanghao Zheng, Xueli Yu, Long Wei, Qiyuan Chen, Yan Xu, Peiyan Ni, Wei Deng, Wanjun Guo, Xun Hu, Xueyu Qi, Tao Li

Journal of Affective Disorders · 2024-12 · 367 · 18-30

DOI: 10.1016/j.jad.2024.08.176 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Affective Disorders, 2024-12. Verfasst von Yanghao Zheng und 10 weiteren Autor:innen. Beteiligte Einrichtung: Affiliated Mental Health Center & Hangzhou Seventh People's Hospital, Zhejiang University School of Medicine, Hangzhou 310058, China; Nanhu Brain-com…. Hauptthemen laut MEDLINE: Depression, Neuronal Plasticity, Prefrontal Cortex, Receptors, AMPA. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Sleep loss is closely related to the onset and development of depression, and the mechanisms involved may include impaired synaptic plasticity. Considering the important role of glutamate α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptors (AMPARs) in synaptic plasticity as well as depression, we introduce LT-102, a novel AMPARs potentiator, to evaluate the potential of LT-102 in treating sleep deprivation-induced depression-like behaviors. METHODS: We conducted a comprehensive behavioral assessment to evaluate the effects of LT-102 on depression-like symptoms in male C57BL/6J mice. This assessment included the open field test to measure general locomotor activity and anxiety-like behavior, the forced swimming test and tail suspension test to assess despair behaviors indicative of depressive states, and the sucrose preference test to quantify anhedonia, a core symptom of depression. Furthermore, to explore the impact of LT-102 on synaptic plasticity, we utilized a combination of Western blot analysis to detect protein expression levels, Golgi-Cox staining to visualize neuronal morphology, and immunofluorescence to examine the localization of synaptic proteins. Additionally, we utilized primary cortical neurons to delineate the signaling pathway modulated by LT-102. RESULTS: Treatment with LT-102 significantly reduced depression-like behaviors associated with sleep deprivation. Quantitative Western blot (WB) analysis revealed a significant increase in GluA1 phosphorylation in the prefrontal cortex (PFC), triggering the Ca2+/calmodulin-dependent protein kinase II/cAMP response element-binding protein/brain-derived neurotrophic factor (CaMKII/CREB/BDNF) and forkhead box protein P2/postsynaptic density protein 95 (FoxP2/PSD95) signaling pathways. Immunofluorescence imaging confirmed that LT-102 treatment increased spine density and co-labeling of PSD95 and vesicular glutamate transporter 1 (VGLUT1) in the PFC, reversing the reductions typically observed following sleep deprivation. Golgi staining further validated these results, showing a substantial increase in neuronal dendritic spine density in sleep-deprived mice treated with LT-102. Mechanistically, application of LT-102 to primary cortical neurons, resulted in elevated levels of phosphorylated AKT (p-AKT) and phosphorylated glycogen synthase kinase-3 beta (p-GSK3β), key downstream molecules in the BDNF signaling pathway, which in turn upregulated FoxP2 and PSD95 expression. LIMITATIONS: In our study, we chose to exclusively use male mice to eliminate potential influences of the estrous cycle on behavior and physiology. As there is no widely accepted positive drug control for sleep deprivation studies, we did not include one in our research. CONCLUSION: Our results suggest that LT-102 is a promising therapeutic agent for counteracting depression-like behaviors and synaptic plasticity deficits induced by sleep deprivation, primarily through the activation of CaMKII/CREB/BDNF and AKT/GSK3β/FoxP2/PSD95 signaling pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DepressionNeuronal PlasticityPrefrontal CortexReceptors, AMPASleep DeprivationAnimalsMaleMiceBehavior, AnimalBrain-Derived Neurotrophic FactorDisease Models, AnimalDisks Large Homolog 4 ProteinMice, Inbred C57BLNeuronsSignal Transduction

Stichwörter der Autor:innen

AMPARsDepressionLT-102Sleep deprivationSynaptic plasticity

Substanzen

Brain-Derived Neurotrophic FactorDisks Large Homolog 4 ProteinReceptors, AMPA

Autor:innen und Institutionen

  • Affiliated Mental Health Center & Hangzhou Seventh People's Hospital, Zhejiang University School of Medicine, Hangzhou 310058, China; Nanhu Brain-computer Interface Institute, Hangzhou 311100, China.
  • Affiliated Mental Health Center & Hangzhou Seventh People's Hospital, Zhejiang University School of Medicine, Hangzhou 310058, China; Nanhu Brain-computer Interface Institute, Hangzhou 311100, China; Liangzhu Laboratory…
  • Affiliated Mental Health Center & Hangzhou Seventh People's Hospital, Zhejiang University School of Medicine, Hangzhou 310058, China.
  • The Clinical Research Center and Department of Pathology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zheng, Y., Yu, X., Wei, L., Chen, Q., Xu, Y., Ni, P., Deng, W., Guo, W., Hu, X., Qi, X., & Li, T. (2024). LT-102, an AMPA receptor potentiator, alleviates depression-like behavior and synaptic plasticity impairments in prefrontal cortex induced by sleep deprivation. Journal of Affective Disorders, 367, 18-30. https://doi.org/10.1016/j.jad.2024.08.176

Vancouver

Zheng Y, Yu X, Wei L, Chen Q, Xu Y, Ni P, et al. LT-102, an AMPA receptor potentiator, alleviates depression-like behavior and synaptic plasticity impairments in prefrontal cortex induced by sleep deprivation. Journal of Affective Disorders. 2024;367:18-30. doi:10.1016/j.jad.2024.08.176

BibTeX
@article{Zheng2024,
  author = {Zheng, Yanghao and Yu, Xueli and Wei, Long and Chen, Qiyuan and Xu, Yan and Ni, Peiyan and Deng, Wei and Guo, Wanjun and Hu, Xun and Qi, Xueyu and Li, Tao},
  title = {LT-102, an AMPA receptor potentiator, alleviates depression-like behavior and synaptic plasticity impairments in prefrontal cortex induced by sleep deprivation},
  journal = {Journal of Affective Disorders},
  year = {2024},
  volume = {367},
  pages = {18--30},
  doi = {10.1016/j.jad.2024.08.176}
}
Kostenlos starten →